The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
11-25
Author(s):
Rudi K. Tannenberg, Heather L. Scott, Robert I. Westphalen and Peter R. Dodd
Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
39-46
Author(s):
Masayoshi Takeuchi, Seiji Kikuchi, Nobuyuki Sasaki, Takako Suzuki, Takayuki Watai, Mina Iwaki, Richard Bucala and Sho-ichi Yamagishi
Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
668-668
Author(s):
Masato Asanuma
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
679-686
Author(s):
M. Thomas and W. D. Le
Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinsons Disease
Journal:
Current Drug Targets
Volume:
5
Page:
197-206
Author(s):
L.- W. Chen, K. K.L. Yung and Y S Chan
Subject Index to Volume 9
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
89-108
Author(s):
Bentham Science Publishers
Mitochondrial Generation of Reactive Oxygen Species and its Role in Aerobic Life
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
2495-2505
Author(s):
Masayasu Inoue, Eisuke F. Sato, Manabu Nishikawa, Ah-Mee Park, Yukimi Kira, Isuke Imada and Kozo Utsumi
Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
349-356
Author(s):
Kevin Pong and Margaret M. Zaleska
Cdk5 in the Adult Non-Demented Brain
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
375-381
Author(s):
Andre Fischer, Farahnaz Sananbenesi, Joachim Spiess and Jelena Radulovic
The Molecular Pathology of Huntingtons Disease (HD)
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
329-340
Author(s):
David C. Rubinsztein